Case Report: Effective management of adalimumab-induced acquired hemophilia A with the CyDRI protocol
Sign Up to like & getrecommendations! Published in 2024 at "Pathology and Oncology Research"
DOI: 10.3389/pore.2024.1611720
Abstract: Introduction Acquired Hemophilia A (AHA) is a rare autoimmune disorder characterized by the emergence of inhibitors that specifically target coagulation Factor VIII, frequently resulting in severe bleeding episodes. Methods We conducted a retrospective analysis of… read more here.
Keywords: adalimumab induced; acquired hemophilia; cydri protocol; case report ... See more keywords